Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>The Company involved in Location Master Data Management (LMDM) software and solutions announced it has signed a £1m SaaS contract with UK Power Networks enabling use of the 1Streetworks platform over the next 15 months, with a one-year extension option.</li>
<li>UK Power Networks has 190,000km of cables and undertakes approximately 40,000 works on the highway each year across London, the South-East and East of England, to maintain safe and reliable power supplies to 20 million people.</li>
<li>Over the past year, 1Spatial has engaged with UK Power Networks to realise significant benefits from automating the production of a proportion of the traffic management plans, diversion routing and asset inventory lists, associated with these works.</li>
</ul>


The Company involved in Location Master Data Management (LMDM) software and solutions announced it has signed a £1m SaaS contract with UK Power Networks enabling use of the 1Streetworks platform over the next 15 months, with a one-year extension option.
UK Power Networks has 190,000km of cables and undertakes approximately 40,000 works on the highway each year across London, the South-East and East of England, to maintain safe and reliable power supplies to 20 million people.
Over the past year, 1Spatial has engaged with UK Power Networks to realise significant benefits from automating the production of a proportion of the traffic management plans, diversion routing and asset inventory lists, associated with these works.


Polarean Imaging Plc - Hybridan Small Cap Feast: 06/10/2025

<ul>
<li>8th September: Project Glow Topco Limited, the ultimate holding Company of The Beauty Tech Group Limited, a global leader in the rapidly growing at-home beauty technology market, has confirmed its intention to float on the Main Market.</li>
<li>The Beauty Tech Group encompasses three distinct, innovative and premium beauty technology brands - CurrentBody Skin, ZIIP Beauty and Tria Laser - under which it develops, manufactures and retails at-home beauty devices.</li>
<li>In FY24, the Group reported revenue of £101.1m and adjusted EBITDA of £22.9m. Between the financial period for the 16 months ended 31 January 2023 (FY22) and FY24, the Group's own-brand revenue and adjusted EBITDA grew at a compound annual growth rate of 73.6% and 92.9% respectively. Timing and deal details TBC.</li>
</ul>


8th September: Project Glow Topco Limited, the ultimate holding Company of The Beauty Tech Group Limited, a global leader in the rapidly growing at-home beauty technology market, has confirmed its intention to float on the Main Market.
The Beauty Tech Group encompasses three distinct, innovative and premium beauty technology brands - CurrentBody Skin, ZIIP Beauty and Tria Laser - under which it develops, manufactures and retails at-home beauty devices.
In FY24, the Group reported revenue of £101.1m and adjusted EBITDA of £22.9m. Between the financial period for the 16 months ended 31 January 2023 (FY22) and FY24, the Group's own-brand revenue and adjusted EBITDA grew at a compound annual growth rate of 73.6% and 92.9% respectively. Timing and deal details TBC.


Van Elle Holdings PLC - Hybridan Small Cap Feast: 22/09/2025

Beeks Financial Cloud Group / Equity Bottom-Up

<ul>
<li>The biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, announces that it has concluded a positive Type C meeting with the US Food and Drug Administration (FDA) for AT278 in people with both type 1 and type 2 diabetes with high daily insulin needs.</li>
<li>The purpose of the meeting was to discuss the design of a proposed Phase 2 clinical study for AT278 delivered by continuous infusion via an Automated Insulin Delivery (AID) system, ahead of a planned Investigational New Drug (IND) submission.</li>
<li>Arecor reports they are on track to commence Phase 2 study in mid-2026, subject to further funding.</li>
</ul>


The biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, announces that it has concluded a positive Type C meeting with the US Food and Drug Administration (FDA) for AT278 in people with both type 1 and type 2 diabetes with high daily insulin needs.
The purpose of the meeting was to discuss the design of a proposed Phase 2 clinical study for AT278 delivered by continuous infusion via an Automated Insulin Delivery (AID) system, ahead of a planned Investigational New Drug (IND) submission.
Arecor reports they are on track to commence Phase 2 study in mid-2026, subject to further funding.


<ul>
<li>A cloud computing and connectivity provider for financial markets announced the signing of approximately $10m of Proximity Cloud contracts in June and provided an update on trading for the year ended 30 June 2025 (FY25).</li>
<li>Results for FY25 are expected to once more demonstrate significant double-digit growth on the prior year, driven by a strong performance across Beeks' Private, Proximity and Exchange Cloud offerings.</li>
<li>Revenue for FY25 is expected to have increased by approximately 25% to £35.5m (30 June 2024: £28.5m), with underlying EBITDA growth of 29% to £13.8m (30 June 2024: £10.7m) and underlying profit before tax growth of 41% to £5.5m (30 June 2024: £3.9m). </li>
</ul>


A cloud computing and connectivity provider for financial markets announced the signing of approximately $10m of Proximity Cloud contracts in June and provided an update on trading for the year ended 30 June 2025 (FY25).
Results for FY25 are expected to once more demonstrate significant double-digit growth on the prior year, driven by a strong performance across Beeks' Private, Proximity and Exchange Cloud offerings.
Revenue for FY25 is expected to have increased by approximately 25% to £35.5m (30 June 2024: £28.5m), with underlying EBITDA growth of 29% to £13.8m (30 June 2024: £10.7m) and underlying profit before tax growth of 41% to £5.5m (30 June 2024: £3.9m). 


United Kingdom

Beeks Financial Cloud Group Plc is a technology company that provides managed cloud computing, connectivity, and analytics services exclusively for the capital markets and financial services industry. It offers Infrastructure-as-a-Service (IaaS) solutions optimized for low-latency private cloud compute, connectivity, and analytics. The company is headquartered in Renfrew, Scotland, and was founded in 2011.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Beeks Financial Cloud Group (BKS LN)

Polarean Imaging Plc - Hybridan Small Cap Feast: 06/10/2025

The Company involved in Location Master Data Management (LMDM) software and solutions announced it has signed a £1m SaaS contract with UK Power...

Hybridan

Van Elle Holdings PLC - Hybridan Small Cap Feast: 22/09/2025

The Beauty Tech Group encompasses three distinct, innovative and premium beauty technology brands - CurrentBody Skin, ZIIP Beauty and Tria Laser

Hybridan

Hybridan Small Cap Feast: 04/09/2025

The purpose of the meeting was to discuss the design of a proposed Phase 2 clinical study for AT278 delivered by continuous infusion via an...

Hybridan

Hybridan Small Cap Feast: 14/07/2025

Beeks continued to achieve a positive free cash flow position over the year with unaudited net cash of £6.96m at the period end (30 June 2024 net...

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)